PFM HEALTH SCIENCES, LP
Adviser information for PFM HEALTH SCIENCES, LP last updated from Form ADV on March 30th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 20 |
---|---|
Investment Advisory/Research | 10 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 8 | $2.4B |
Non-Discretionary | 0 | $0 |
Total | 8 | $2.4B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 8 | $2.4B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 25 |
No. of Financial Planning Clients | 0 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
475 SANSOME STREETSUITE 1720
SAN FRANCISCO
CA
United States
Monday - Friday, 6:00 AM - 3:00 PM
Tel: 415-281-1000, Fax: 415-281-1070
Chief Compliance Officer
DARREN WILLIAM MOONEY
CHIEF COMPLIANCE OFFICER
475 SANSOME STREET
SUITE 1720
SAN FRANCISCO
CA
United States
Tel:
415-281-1000
Fax:
415-281-6222
D*****@********M
(Full email address available in API data)
Industry Affiliates
PARTNER ASSET MANAGEMENT LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
PFM HEALTHCARE GROWTH EQUITY I GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
PARTNER INVESTMENTS, L.P. | Hedge Fund | $24.2M | $0.0M | 70 |
PFM BIOTECH OPPORTUNITIES LP | Private Equity Fund | $109.2M | $5.0M | 73 |
PFM HEALTHCARE GROWTH EQUITY FUND I, LP | Private Equity Fund | $56.4M | $5.0M | 46 |
PFM HEALTHCARE MASTER FUND, L.P. | Hedge Fund | $2,232.6M | $0.0M | 425 |
PFM META, LP | Private Equity Fund | $3.7M | $0.0M | 10 |
PFM SONGBIRD, LP | Private Equity Fund | $3.7M | $0.0M | 10 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
GROSSMAN, BRIAN, DAVID | Individual | – | LIMITED PARTNER, PORTFOLIO MANAGER | 02/2008 | > 75% |
GROSSMAN, BRIAN, DAVID | Individual | PFM HEALTH SCIENCES GP LLC | MANAGING MEMBER | 10/2020 | > 75% |
PFM HEALTH SCIENCES GP LLC | Domestic Entity | – | GENERAL PARTNER | 10/2020 | < 5% |
MOONEY, DARREN, WILLIAM | Individual | – | CHIEF COMPLIANCE OFFICER | 05/2023 | < 5% |
ALJOE, JONATHAN, JUDE | Individual | – | CHIEF FINANCIAL OFFICER | 06/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABBVIE INC | COM | 69M | 404K | – |
ACADIA HEALTHCARE COMPANY IN | COM | 28M | 420K | – |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 10M | 11M | – |
ALKERMES PLC | SHS | 5M | 205K | – |
AMGEN INC | COM | 25M | 81K | – |
APELLIS PHARMACEUTICALS INC | COM | 3M | 83K | – |
ARCELLX INC | COMMON STOCK | 17M | 312K | – |
ARGENX SE | SPONSORED ADR | 37M | 87K | – |
ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 | 20M | – | – |
AXSOME THERAPEUTICS INC | COM | 38M | 467K | – |
BECTON DICKINSON & CO | COM | 31M | 131K | – |
BIOMARIN PHARMACEUTICAL INC | NOTE 0.599% 8/0 | 15M | – | – |
BOSTON SCIENTIFIC CORP | COM | 27M | 348K | – |
BOUNDLESS BIO INC | COM | 544K | 141K | – |
CARIBOU BIOSCIENCES INC | COM | 7M | 4M | – |
CELCUITY INC | COM | 14M | 837K | – |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 2M | 52K | – |
CENTENE CORP DEL | COM | 40M | 599K | – |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 6M | 636K | – |
COMPASS PATHWAYS PLC | SPONSORED ADS | 7M | 1M | – |
CULLINAN THERAPEUTICS INC | COM | 5M | 296K | – |
CYTOKINETICS INC | COM NEW | 95M | 2M | – |
DANAHER CORPORATION | COM | 31M | 126K | – |
DAY ONE BIOPHARMACEUTICALS I | COM | 5M | 397K | – |
DEXCOM INC | COM | 26M | 231K | – |
EDWARDS LIFESCIENCES CORP | COM | 68M | 740K | – |
ELEVANCE HEALTH INC | COM | 30M | 55K | – |
ELI LILLY & CO | COM | 270M | 299K | – |
ERASCA INC | COM | 11M | 5M | – |
ESSA PHARMA INC | COM NEW | 16M | 3M | – |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 3M | 293K | – |
GENERATION BIO CO | COM | 2M | 788K | – |
HCA HEALTHCARE INC | COM | 40M | 125K | – |
HUMANA INC | COM | 47M | 125K | – |
ICON PLC | SHS | 37M | 117K | – |
IMMUNOVANT INC | COM | 12M | 473K | – |
INHIBRX BIOSCIENCES INC | COM | 2M | 136K | – |
INSMED INC | COM PAR $.01 | 16M | 241K | – |
INTRA-CELLULAR THERAPIES INC | COM | 12M | 170K | – |
INTUITIVE SURGICAL INC | COM NEW | 61M | 137K | – |
INVESCO QQQ TR | UNIT SER 1 | 90M | 187K | – |
IO BIOTECH INC | COM | 3M | 2M | – |
IOVANCE BIOTHERAPEUTICS INC | COM | 1M | 153K | – |
IQVIA HLDGS INC | COM | 24M | 112K | – |
ISHARES TR | RUSSELL 2000 ETF | 14M | 71K | – |
JOHNSON & JOHNSON | COM | 19M | 129K | – |
KEROS THERAPEUTICS INC | COM | 2M | 33K | – |
MADRIGAL PHARMACEUTICALS INC | COM | 8M | 30K | – |
MCKESSON CORP | COM | 57M | 97K | – |
MERCK & CO INC | COM | 74M | 596K | – |
METAGENOMI INC | COM | 5M | 1M | – |
MOLINA HEALTHCARE INC | COM | 21M | 70K | – |
OSCAR HEALTH INC | CL A | 14M | 861K | – |
OUTSET MED INC | COM | 3M | 745K | – |
PENUMBRA INC | COM | 33M | 185K | – |
PMV PHARMACEUTICALS INC | COM | 2M | 1M | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 19M | 453K | – |
SAGIMET BIOSCIENCES INC | COM SER A | 2M | 649K | – |
SANA BIOTECHNOLOGY INC | COM | 605K | 111K | – |
SAREPTA THERAPEUTICS INC | COM | 14M | 88K | – |
SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 | 10M | – | – |
SPDR SER TR | S&P BIOTECH | 55M | 595K | – |
STRYKER CORPORATION | COM | 39M | 114K | – |
SYNDAX PHARMACEUTICALS INC | COM | 8M | 387K | – |
TENAYA THERAPEUTICS INC | COM | 689K | 222K | – |
TENET HEALTHCARE CORP | COM NEW | 78M | 589K | – |
THERMO FISHER SCIENTIFIC INC | COM | 35M | 64K | – |
TURNSTONE BIOLOGICS CORP | COM | 2M | 932K | – |
UNIQURE NV | SHS | 1M | 275K | – |
UNITEDHEALTH GROUP INC | COM | 27M | 52K | – |
UNITEDHEALTH GROUP INC | COM | 35M | 69K | – |
UNIVERSAL HLTH SVCS INC | CL B | 40M | 214K | – |
VERTEX PHARMACEUTICALS INC | COM | 70M | 149K | – |
VIKING THERAPEUTICS INC | COM | 3M | 59K | – |
WATERS CORP | COM | 6M | 21K | – |
WAYSTAR HLDG CORP | COM | 753K | 35K | – |
WEREWOLF THERAPEUTICS INC | COM | 8M | 3M | – |
XENON PHARMACEUTICALS INC | COM | 6M | 151K | – |